Physio-Control acquires Jolife
This article was originally published in Clinica
Medtronic subsidiary Physio-Control has bought Jolife, a Swedish specialist in chest compression technology, for an undisclosed fee. Privately-held, Lund-based Jolife's flagship product is the LUCAS automated chest compression system, which Physio-Control has distributed on an exclusive basis since 2004. Physio-Control says the acquisition complements its existing offerings used during cardiac resuscitation, including the LIFEPAK line of external defibrillators and monitors. The Redmond, Washington firm believes that the LUCAS technology, which is sold in most major markets, will "become a mainstay in the field of resuscitation in the future". Last week, Medtronic said it was increasing its efforts to sell Physio-Control after reporting modest financial growth (www.clinica.co.uk, 23 February 2011). The business has a lower profit margin compared to other Medtronic businesses, despite recording fiscal Q3 sales of $104m, a 4% increase over the previous year.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.